Beer Drinking: Liver Damage Risks And Realities

Alcoholic liver disease is a condition that can develop after years of heavy drinking. It is characterised by liver damage and dysfunction due to alcohol abuse. The liver is a complex organ that performs a variety of functions, including filtering toxins from the blood, aiding digestion, regulating blood sugar and cholesterol levels, and fighting infections. While the liver is resilient and capable of regenerating itself, prolonged alcohol misuse can reduce its ability to regenerate, leading to serious and permanent damage. Beer, like any other alcoholic beverage, contributes to the overall alcohol intake, which can have detrimental effects on the liver. Therefore, it is important to understand the relationship between beer consumption and liver health to prevent potential damage.

Alcoholic fatty liver disease

The good news is that alcoholic fatty liver disease is reversible. If you stop drinking alcohol for a period of time (ranging from two weeks to several months or years), your liver should return to normal. The best treatment is for the patient to stop drinking.

If alcoholic fatty liver disease is left untreated, it can progress to the next stages of alcohol-related liver disease: alcoholic hepatitis and cirrhosis. Alcoholic hepatitis is a potentially serious condition that can occur from alcohol misuse over a longer period. It can also occur from binge drinking. Severe alcoholic hepatitis is life-threatening. Cirrhosis is a stage where the liver has become significantly scarred, and it is generally not reversible. However, stopping drinking alcohol immediately can prevent further damage and increase life expectancy.

Alcoholic hepatitis

The clinical presentation of alcoholic hepatitis ranges from mild to severe. A mild case may present with fever, right upper quadrant pain or discomfort, and elevated aminotransferase levels that normalise with sobriety. In contrast, a severe case may include jaundice, ascites, hepatic encephalopathy, and coagulopathy. The physical examination may reveal tachycardia, tachypnea, fever, an enlarged liver, and signs of portal hypertension.

The treatment of alcoholic hepatitis focuses on abstinence from alcohol and adequate nutritional support. Abstinence is crucial, as continued drinking can lead to the progression of alcoholic hepatitis to cirrhosis. For those who discontinue alcohol, the inflammation associated with alcoholic hepatitis typically resolves within a few months. However, the cirrhosis that has already occurred may not be reversible.

Mild alcoholic hepatitis generally has a benign course and is completely reversible with the cessation of alcohol consumption. However, severe alcoholic hepatitis can be life-threatening, with a 30-day mortality rate of 30-50%. Jaundice and hepatic encephalopathy at the time of presentation indicate a poorer outcome.

Cirrhosis

The liver is responsible for various vital functions in the body, including detoxification of the blood, regulating blood sugar and cholesterol levels, and aiding digestion. When the liver is damaged by alcohol, it can continue to function due to its regenerative capabilities. However, prolonged alcohol misuse over many years can reduce its ability to regenerate, leading to permanent damage.

The best course of treatment for cirrhosis is to stop consuming alcohol immediately. Abstinence from alcohol can prevent further damage, improve life expectancy, and slow or reverse the progression of the disease. In severe cases where the liver has stopped functioning, a liver transplant may be required. However, it is important to note that even with treatment, cirrhosis can lead to fatal complications, such as liver failure or liver cancer.

Alcohol-induced liver cancer

Alcoholic liver disease (ALD) refers to liver damage caused by excessive alcohol consumption. ALD is very common in the UK, with the number of people with the condition rising over the last few decades due to increasing levels of alcohol misuse. ALD is caused by drinking too much alcohol over a long period, or binge drinking. Binge drinking is defined as consuming five or more drinks within two hours for men, and at least four drinks for women.

ALD can lead to hepatocellular carcinoma (HCC), a type of liver cancer. Alcohol consumption is associated with a two-fold increased risk of two types of liver cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma. ALD is a preventable disease, and it is reversible if treated early. The best treatment is for the patient to stop drinking.

There are three main stages of ALD:

• Alcoholic fatty liver disease: This is the earliest stage of ALD and is characterised by a build-up of fats in the liver. Fatty liver disease rarely causes any symptoms but is an important warning sign that someone is drinking at a harmful level.
• Alcoholic hepatitis: Alcoholic hepatitis is a potentially serious condition that can be caused by alcohol misuse over a longer period. It can also occur if someone binge drinks. Alcoholic hepatitis can be life-threatening and often goes undetected until it reaches an advanced stage.
• Cirrhosis: Cirrhosis is a late stage of ARLD where the liver has become significantly scarred. It is generally irreversible, but stopping drinking alcohol immediately can prevent further damage and increase life expectancy.

The more someone drinks above the recommended limits, the higher their risk of developing ARLD. Other factors that can increase the chances of developing ARLD include being overweight or obese, being female, having a pre-existing liver condition, and genetics.

Acute alcoholic hepatitis

Alcoholic hepatitis is an acute form of alcoholic liver disease, characterised by a rapid decline in hepatic function. The disease is typically diagnosed in adults aged 40 to 50 years, but it has been observed in patients as young as 20 and as old as 80. The diagnosis is primarily based on clinical presentation, with patients providing a history of excessive alcohol consumption over a prolonged period (more than 2 decades). However, it is now recognised that many patients diagnosed with alcoholic hepatitis report alcohol use over shorter periods.

The clinical presentation of acute alcoholic hepatitis can be subdivided into four broad categories:

• Features specific to existing alcoholic hepatitis: Clinical jaundice is present in 40%-60% of cases, but hyperbilirubinemia is observed in almost every patient and is considered a cardinal feature. Other symptoms include right upper quadrant pain, fever, tachycardia, and tender enlarged liver. Hepatic bruit, characterised by increased blood flow, is also characteristic but less commonly observed.
• Features due to underlying cirrhosis: Concomitant cirrhosis is present in about 50%-60% of cases. Patients may exhibit spider angiomas, palmar erythema, ascites, and variceal bleeding. Other common features include Dupuytren's contracture, gynecomastia, loss of pubic or axillary hair, parotid gland enlargement, and testicular atrophy in males, and amenorrhea with infertility in females.
• Signs of alcohol withdrawal: Patients with alcoholic hepatitis may present with withdrawal symptoms, ranging from mild to severe. Mild to moderate symptoms include irritability, anxiety, headache, sweating, tachycardia, and hand tremors with clammy skin. Severe symptoms include delirium tremens, where patients experience confusion, visual hallucinations, agitation, convulsions, and fever.
• Non-specific symptoms: Other non-specific symptoms associated with alcoholic hepatitis include nausea, vomiting, malaise, and anorexia. The frequency and severity of these symptoms vary with the severity of the disease.

The diagnosis of alcoholic hepatitis is based on clinical presentation and a history of alcohol abuse. Laboratory findings show elevated aspartate aminotransferase (AST) levels, 2–6 times the upper limit of normal, and elevated alanine aminotransferase (ALT) levels to a lesser extent, resulting in an AST:ALT ratio of >2. Leukocytosis, hyperbilirubinemia, and prolonged prothrombin time are also commonly observed.

Several scoring models have been developed to assess the severity of the disease, predict mortality, and guide treatment decisions. These include the Maddrey discriminant function (DF), the model for end-stage liver disease (MELD) score, the Glasgow alcoholic hepatitis score (GAHS), and the Lille score.

The treatment for alcoholic hepatitis involves abstinence from alcohol, which is crucial for preventing further liver damage and improving life expectancy. In severe cases, corticosteroid therapy may be initiated, and a liver transplant may be required if the condition progresses to end-stage liver disease.

Frequently asked questions